Search results for Ontuxizumab
Ontuxizumab Biosimilar – Anti-CD248 mAb – Research Grade, ProteoGenix, PX-TA1346
Description of Ontuxizumab Biosimilar - Anti-CD248 mAb - Research Grade General information on Anti-CD248[Homo sapiens] (Ontuxizumab) Monoclonal Antibody Ontuxizumab monoclonal antibody targets CD248. It has been used in the treatment of cancer.
Host
Reactivity
Applications
Conjugation
Ontuxizumab, Abbexa, abx831305
Ontuxizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD248, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Ontuxizumab(MORAb-004)是一种干扰内皮唾液酸蛋白(肿瘤内皮标志-1)的单克隆抗体。
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Ontuxizumab Biosimilar - Research Grade, ichor.bio, ICH5736
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Ontuxizumab (HV681016), abinScience, HV681016
Host
Humanized
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.